Tela Bio outlines at least 16% 2025 revenue growth target while strengthening commercial ...

Q3 2025 Management View Antony Koblish, CEO, emphasized the company's continued execution on expanding its commercial footprint, improving operating discipline, and strengthening its patient-centric ...